Khan Farah D, Roychowdhury Sanjoy, Gaspari Anthony A, Svensson Craig K
University of Iowa, Division of Pharmaceutics, College of Pharmacy, 115 S. Grand Avenue, 201 PHAR, Iowa City, IA 52242, USA.
Expert Opin Drug Metab Toxicol. 2006 Apr;2(2):261-72. doi: 10.1517/17425255.2.2.261.
Skin is the most frequent target of adverse drug reactions. These cutaneous drug reactions (CDRs) show varied clinical manifestations ranging from mildly discomforting rashes to life-threatening Stevens-Johnson syndrome or toxic epidermal necrolysis. Most CDRs appear to be immune mediated, although the mechanism by which they are initiated remains unclear. In this review, current knowledge of the mechanisms by which xenobiotics provoke immune responses in the skin after epicutaneous administration and how similar reactions may occur after systemic routes are summarised. This review also discusses a variety of genetic or environmental factors that may determine the susceptibility of individuals towards immune responses in skin following drug exposure.
皮肤是药物不良反应最常见的靶器官。这些皮肤药物反应(CDR)表现出多样的临床表现,从轻度不适的皮疹到危及生命的史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症。尽管引发这些反应的机制尚不清楚,但大多数CDR似乎是免疫介导的。在这篇综述中,总结了目前关于外源性物质经皮给药后在皮肤中引发免疫反应的机制以及全身给药后如何发生类似反应的知识。这篇综述还讨论了各种可能决定个体在药物暴露后对皮肤免疫反应易感性的遗传或环境因素。